Related Experiment Videos
Interleukin-1 activates phospholipase A2 in human synovial cells
S C Gilman1, J Chang, P R Zeigler
1Division of Experimental Therapeutics, Wyeth Laboratories, Philadelphia, PA 19101.
Arthritis and Rheumatism
|January 1, 1988
Summary
Interleukin-1 (IL-1) induces phospholipase A2 (PLA2) secretion in synovial cells from arthritis patients. This PLA2 activation, alongside prostaglandin E2 and plasminogen activator synthesis, suggests a role in IL-1-mediated inflammation.
Area of Science:
- Rheumatology
- Immunology
- Biochemistry
Background:
- Rheumatoid arthritis and osteoarthritis involve synovial inflammation.
- Interleukin-1 (IL-1) is a key pro-inflammatory cytokine in joint diseases.
- Phospholipase A2 (PLA2) activity is implicated in inflammatory processes.
Purpose of the Study:
- To investigate the effect of Interleukin-1 (IL-1) on phospholipase A2 (PLA2) secretion in synovial cells.
- To determine the relationship between IL-1, PLA2, prostaglandin E2, and plasminogen activator.
- To characterize the optimal conditions for synovial cell PLA2 activity.
Main Methods:
- Synovial cells from arthritis patients were treated with varying doses of IL-1.
- Secretion of PLA2, prostaglandin E2, and plasminogen activator was measured over time.
- PLA2 activity was assessed under different calcium concentrations and pH levels.
Main Results:
- IL-1 treatment caused a dose-dependent increase in PLA2 secretion.
- Prostaglandin E2 and plasminogen activator synthesis were stimulated in parallel with PLA2 activation.
- Maximal PLA2 activity was observed at 5 mM calcium and pH 7.5, similar to synovial fluid PLA2.
Conclusions:
- IL-1 can induce PLA2 secretion in synovial cells.
- Induced PLA2 secretion may significantly contribute to the inflammatory effects of IL-1 in arthritis.
- The findings highlight a potential therapeutic target for inflammatory joint diseases.